Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T80603 | Dresbuxelimab | 2550560-20-6 | 98% |
Dresbuxelimab
|
Dresbuxelimab (AK-119), an IgG-κ monoclonal antibody, selectively targets CD73 and is commonly produced using a Chinese Hamster Ovary (CHO) cell expression syste... | ||||
T12569L | PSB-12379 ditriethylamine salt | T12569L | 99.75% |
|
PSB-12379 ditriethylamine salt, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase (CD73) inhibitor with Kis of 9.03 nM (rat) and 2.21 nM (human). | ||||
T10216 | AB-680 | 2105904-82-1 | 97.98% |
|
AB-680 is a highly potent, reversible, and selective inhibitor of CD73 (an ectonucleotidase, Ki: 4.9 pM for hCD73) with anti-tumor activity, displays >10,000-fol... | ||||
T9210 | CD73-IN-4 | 2216764-29-1 | 98% |
|
CD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor | ||||
T76735 | Mupadolimab | 2451856-97-4 | 98% |
Mupadolimab
|
Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells. | ||||
T10721 | CD73-IN-1 | 2132396-40-6 | 98% |
|
CD73-IN-1 is a CD73 inhibitor with anticancer activity. | ||||
T8875 | CD73-IN-3 | 2375815-63-5 | 98% |
|
CD73-IN-3 (LY-3475070) is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being ... |